Funds holding AGOMAB THERAPEUTICS SA
ISIN US00860C1027 · Belgium · LEI 894500APP6UE5N4PKJ68
- Fund holders
- 10
- Of which ETFs
- 0 10 other funds
- Value held
- 30.1M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 981,184 | 12.6M $ | 0.26 % | as of Jul 31, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 615,708 | 7.9M $ | 0.28 % | as of Jul 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 507,877 | 5.7M $ | 0.01 % | as of May 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 141,356 | 1.6M $ | 0.01 % | as of May 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 129,200 | 1.5M $ | 0.01 % | as of May 31, 2026 ↗ |
| Federated Hermes Kaufmann Fund II Federated Hermes Insurance Series | 21,108 | 274K $ | 0.24 % | as of Jun 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 17,665 | 229.3K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| Select Pharmaceuticals Portfolio Fidelity Select Portfolios | 9,100 | 102.4K $ | 0.01 % | as of May 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 8,746 | 98.4K $ | 0.00 % | as of May 31, 2026 ↗ |
| Steward Values Enhanced International Fund Steward Funds Inc | 4,109 | 52.9K $ | 0.02 % | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 0.28 % | as of Jul 31, 2026 ↗ |
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 0.26 % | as of Jul 31, 2026 ↗ |
| Federated Hermes Kaufmann Fund II Federated Hermes Insurance Series | 0.24 % | as of Jun 30, 2026 ↗ |
| Steward Values Enhanced International Fund Steward Funds Inc | 0.02 % | as of Jul 31, 2026 ↗ |
| Select Pharmaceuticals Portfolio Fidelity Select Portfolios | 0.01 % | as of May 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 0.01 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 0.01 % | as of May 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 0.01 % | as of May 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 0.01 % | as of May 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 10 | +3 | 2,436,053 | +1.2 % |
| 2026Q2 | 7 | 2,407,377 |
Institutional managers
32 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| EQT Fund Management S.a r.l. | 5,141,992 | 53.9M $ | as of Mar 31, 2026 |
| Sanofi | 2,783,096 | 29.2M $ | as of Mar 31, 2026 |
| Cormorant Asset Management, LP | 2,465,348 | 25.9M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 2,053,233 | 21.5M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 1,618,000 | 17M $ | as of Mar 31, 2026 |
| Casdin Capital, LLC | 1,550,000 | 16.3M $ | as of Mar 31, 2026 |
| ANDERA PARTNERS | 1,538,702 | 16.1M $ | as of Mar 31, 2026 |
| FMR LLC | 1,458,677 | 15.3M $ | as of Mar 31, 2026 |
| Nantahala Capital Management, LLC | 1,200,000 | 12.9M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 707,656 | 7.4M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 600,000 | 6.3M $ | as of Mar 31, 2026 |
| SAMSARA BIOCAPITAL, LLC | 600,000 | 6.3M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 411,250 | 4.3M $ | as of Mar 31, 2026 |
| LMR Partners LLP | 300,000 | 3.1M $ | as of Mar 31, 2026 |
| SEVEN GRAND MANAGERS, LLC | 200,000 | 2.1M $ | as of Mar 31, 2026 |
| Redmile Group, LLC | 156,250 | 1.6M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 95,233 | 999K $ | as of Mar 31, 2026 |
| Pfizer Inc | 75,000 | 813.8K $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 75,000 | 786.8K $ | as of Mar 31, 2026 |
| Bellevue Group AG | 50,000 | 524.5K $ | as of Mar 31, 2026 |
| Laurion Capital Management LP | 50,000 | 524.5K $ | as of Mar 31, 2026 |
| SECTORAL ASSET MANAGEMENT INC | 43,500 | 477.3K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 35,739 | 374.9K $ | as of Mar 31, 2026 |
| Burkehill Global Management, LP | 35,000 | 367.2K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 35,000 | 367.2K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding AGOMAB THERAPEUTICS SA". https://titelia.com/en/stocks/agomab-therapeutics-sa-US00860C1027